114 related articles for article (PubMed ID: 26733159)
1. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma.
Al-Gayyar MM; Abbas A; Hamdan AM
Biol Chem; 2016 Mar; 397(3):257-67. PubMed ID: 26733159
[TBL] [Abstract][Full Text] [Related]
2. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats.
Nazmy EA; El-Khouly OA; Zaki MMA; Elsherbiny NM; Said E; Al-Gayyar MMH; Salem HA
Environ Toxicol Pharmacol; 2019 Nov; 72():103240. PubMed ID: 31421311
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro.
Alyoussef A; Al-Gayyar MMH
Biomed Pharmacother; 2018 Jul; 103():362-372. PubMed ID: 29669302
[TBL] [Abstract][Full Text] [Related]
6. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
[TBL] [Abstract][Full Text] [Related]
7. The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.
Zheng X; Gai X; Han S; Moser CD; Hu C; Shire AM; Floyd RA; Roberts LR
Genes Chromosomes Cancer; 2013 Mar; 52(3):225-36. PubMed ID: 23109092
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB.
Al-Gayyar MMH; Bagalagel A; Noor AO; Almasri DM; Diri R
Biomed Pharmacother; 2019 Apr; 112():108653. PubMed ID: 30784932
[TBL] [Abstract][Full Text] [Related]
9. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic Activity of Chrysin against Human Hepatocellular Carcinoma: New Insight on GPC3/SULF2 Axis and lncRNA-AF085935 Expression.
Sherif IO; Al-Mutabagani LA; Sabry D; Elsherbiny NM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076548
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.
Chen G; Nakamura I; Dhanasekaran R; Iguchi E; Tolosa EJ; Romecin PA; Vera RE; Almada LL; Miamen AG; Chaiteerakij R; Zhou M; Asiedu MK; Moser CD; Han S; Hu C; Banini BA; Oseini AM; Chen Y; Fang Y; Yang D; Shaleh HM; Wang S; Wu D; Song T; Lee JS; Thorgeirsson SS; Chevet E; Shah VH; Fernandez-Zapico ME; Roberts LR
Cancer Res; 2017 Feb; 77(3):632-645. PubMed ID: 27872089
[TBL] [Abstract][Full Text] [Related]
12. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
[TBL] [Abstract][Full Text] [Related]
14. QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model.
Al-Gayyar MMH; Alattar A; Alshaman R; Hamdan AM
Cytokine; 2021 Dec; 148():155710. PubMed ID: 34564023
[TBL] [Abstract][Full Text] [Related]
15. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis
El-Far YM; Khodir AE; Noor AO; Almasri DM; Bagalagel AA; Diri RM; Kutbi HI; Al-Gayyar MMH
Redox Rep; 2020 Dec; 25(1):17-25. PubMed ID: 32172678
[No Abstract] [Full Text] [Related]
16. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis.
Afzal M; Bhardwaj DP; Khan R; Kazmi I; Saleem S; Al-Abbasi FA; Anwar F
Inflammopharmacology; 2019 Feb; 27(1):89-98. PubMed ID: 29728874
[TBL] [Abstract][Full Text] [Related]
18. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
19. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.
Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V
Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141
[TBL] [Abstract][Full Text] [Related]
20. Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.
Lai JP; Thompson JR; Sandhu DS; Roberts LR
Future Oncol; 2008 Dec; 4(6):803-14. PubMed ID: 19086847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]